Angerer, M.; Wülfing, C.; Andura, O.; Franke, M.; Stelzl, D.R.; Dieckmann, K.-P.
Feasibility and Oncological Safety of Robotic Retroperitoneal Lymph Node Dissection in Patients with Testicular Cancer—Single-Center Experience. Cancers 2025, 17, 1439.
https://doi.org/10.3390/cancers17091439
AMA Style
Angerer M, Wülfing C, Andura O, Franke M, Stelzl DR, Dieckmann K-P.
Feasibility and Oncological Safety of Robotic Retroperitoneal Lymph Node Dissection in Patients with Testicular Cancer—Single-Center Experience. Cancers. 2025; 17(9):1439.
https://doi.org/10.3390/cancers17091439
Chicago/Turabian Style
Angerer, Markus, Christian Wülfing, Osama Andura, Mattis Franke, Daniel Robert Stelzl, and Klaus-Peter Dieckmann.
2025. "Feasibility and Oncological Safety of Robotic Retroperitoneal Lymph Node Dissection in Patients with Testicular Cancer—Single-Center Experience" Cancers 17, no. 9: 1439.
https://doi.org/10.3390/cancers17091439
APA Style
Angerer, M., Wülfing, C., Andura, O., Franke, M., Stelzl, D. R., & Dieckmann, K.-P.
(2025). Feasibility and Oncological Safety of Robotic Retroperitoneal Lymph Node Dissection in Patients with Testicular Cancer—Single-Center Experience. Cancers, 17(9), 1439.
https://doi.org/10.3390/cancers17091439
